SPECTRUM PHARMACEUTICALS INC | 6,933 Euro | +0,701 +11,25 % | |
| WKN: 164623 ISIN: US84763A1088 Ticker-Symbol: NTR | Frankfurt | 23.05.13 | 08:03 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 23.05. | Downtrend Call Working As Spectrum Pharmaceuticals Stock Falls 24.0% | 1 | SmarTrend | |
| 21.05. | SPECTRUM PHARMACEUTICALS INC - 8-K, Current Report | 6 | SEC Filings | |
| 21.05. | Spectrum Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-20-2013 03:30 PM | 7 | Seeking Alpha | |
| 17.05. | Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma | 30 | The Street | |
| 15.05. | Spectrum Pharmaceuticals' CEO Presents at Bank of America Merrill Lynch Health Care Conference (Transcript) | 9 | Seeking Alpha | |
| 13.05. | SEC Is Investigating Spectrum Pharma | 12 | The Street | |
| 09.05. | Spectrum Pharmaceuticals Management Discusses Q1 2013 Results - Earnings Call Transcript | 7 | Seeking Alpha | |
| 09.05. | SPECTRUM PHARMACEUTICALS INC - 8-K, Current Report | 5 | SEC Filings | |
| 07.05. | SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of May 13, 2013 to Seek a Lead Plaintiff Position | 43 | PR Newswire | |
| NEW YORK, May 7, 2013 /PRNewswire/ --Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of investors... Mehr lesen zu: SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of May 13, 2013 to Seek a Lead Plaintiff Position | ||||
| 26.04. | Possible Bearish Inside Day Candle Pattern Detected for Spectrum Pharmaceuticals | 6 | SmarTrend | |
| 26.04. | Spectrum Pharmaceuticals Down 34.0% Since SmarTrend Downtrend Call | 7 | SmarTrend | |
| 17.04. | Possible Bullish Inside Day Candle Pattern Detected for Spectrum Pharmaceuticals | 3 | SmarTrend | |
| 17.04. | Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope | 118 | PR Newswire | |
| LONDON, April 17, 2013 /PRNewswire/ --
In 2012, patents on several blockbuster drugs expired, leading to increasing competition from generic drug manufacturers. Major drug manufacturers are likely... Mehr lesen zu: Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope | ||||
| 12.04. | Possible Bearish Inside Day Candle Pattern Detected for Spectrum Pharmaceuticals | 2 | SmarTrend | |
| 11.04. | Saxena White P.A. Files Securities Fraud Class Action Against Spectrum Pharmaceuticals, Inc. | 42 | Marketwired | |
| BOCA RATON, FL -- (Marketwired) -- 04/11/13 -- Saxena White P.A. has filed a securities fraud class action lawsuit in the United States District Court for the District of Nevada against Spectrum Pharmaceuticals... Mehr lesen zu: Saxena White P.A. Files Securities Fraud Class Action Against Spectrum Pharmaceuticals, Inc. | ||||
| 08.04. | Spectrum Pharma (SPPI) Commences SPI-2012 Phase 2 | 5 | StreetInsider.com | |
| 05.04. | SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of May 13, 2013 to Seek a Lead Plaintiff Position | 54 | Marketwired | |
| NEW YORK, NY -- (Marketwired) -- 04/04/13 -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Nevada on behalf of investors... Mehr lesen zu: SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Spectrum Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of May 13, 2013 to Seek a Lead Plaintiff Position | ||||
| 01.04. | Can Spectrum Pharmaceuticals Regain Investor Trust? | 3 | Seeking Alpha | |
| 28.03. | Downtrend Call Working As Spectrum Pharmaceuticals Stock Falls 32.4% | 6 | SmarTrend | |
| 22.03. | Lifshitz Law Firm Announces Investigation of Navistar International Corporation, Spectrum Pharmaceuticals, Inc., and Tech Data Corporation | 73 | PR Newswire | |
| NEW YORK, March 22, 2013 /PRNewswire/ --
Navistar International Corporation
Lifshitz Law Firm announces that that a class action suit was filed in the United States District Court for the Northern... Mehr lesen zu: Lifshitz Law Firm Announces Investigation of Navistar International Corporation, Spectrum Pharmaceuticals, Inc., and Tech Data Corporation | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| ARIAD PHARMACEUTICALS | 14,25 | -1,28 % | Ariad's Cancer Drug Iclusig Extends The Gleevec Magic |
| CELGENE | 96,05 | -2,80 % | Celgene: FDA Grants Priority Review For ABRAXANE SNDA |
| STADA ARZNEIMITTEL | 33,905 | -0,57 % | Stada: Deutsche Bank zeigt Interesse |
| GILEAD SCIENCES | 43,00 | -1,61 % | Maximieren Sie Ihren Ertrag in nur 30 Minuten! (Freenet +370% / Technotrans +100% / Gilead +120% ...) |
| ARRAY BIOPHARMA | 4,416 | -2,84 % | Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript) |
